Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amanda B. Muir"'
Autor:
David A. Hill, Amanda B. Muir
Publikováno v:
Frontiers in Allergy, Vol 4 (2023)
Externí odkaz:
https://doaj.org/article/9a9b025fe4af41158bcd14108a5ba5f4
Autor:
Deirdre Burke, Chris A. Liacouras, Antonella Cianferoni, Amanda B. Muir, Terri F. Brown-Whitehorn, Megan Lewis, Jonathan M. Spergel
Publikováno v:
Allergy. 76:1573-1576
Autor:
Kathleen E. Sullivan, Kelly Maurer, Melanie A. Ruffner, Zhe Zhang, Amanda B. Muir, Jonathan M. Spergel, Antonella Cianferoni
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 7, Pp n/a-n/a (2021)
Objective There are no disease‐modifying therapies for the treatment of eosinophilic oesophagitis (EoE), which is driven by non‐IgE‐mediated allergic inflammation. A recent clinical trial of milk epicutaneous immunotherapy (EPIT) has shown init
Autor:
Melanie A, Ruffner, Zhe, Zhang, Kelly, Maurer, Amanda B, Muir, Antonella, Cianferoni, Kathleen E, Sullivan, Jonathan M, Spergel
Publikováno v:
Clinical & Translational Immunology
Objective There are no disease‐modifying therapies for the treatment of eosinophilic oesophagitis (EoE), which is driven by non‐IgE‐mediated allergic inflammation. A recent clinical trial of milk epicutaneous immunotherapy (EPIT) has shown init
Autor:
Antonella Cianferoni, Benjamin J. Wilkins, Amanda B. Muir, Terri F. Brown-Whitehorn, Deirdre Burke, Chris A. Liacouras, Megan Lewis, Jonathan M. Spergel, Okan U. Elci
Publikováno v:
Clinical Gastroenterology and Hepatology. 18:328-336.e7
Background & Aims Eosinophilic esophagitis (EoE) is caused by an immune response to specific food allergens. There are no approved therapies beyond avoidance of the allergen(s) or treatment of inflammation. Epicutaneous immunotherapy (EPIT) reduces f
Autor:
Thomas A.E. Platts-Mills, Lisa A. Spencer, Marion Groetch, Wendy Book, Mirna Chehade, Joshua B. Wechsler, Chris A. Liacouras, Joshua Friedlander, Marc E. Rothenberg, Kara Kliewer, Ting Wen, Amanda B. Muir, Seema S. Aceves, Nirmala Gonsalves, Antonella Cianferoni, Leah C. Kottyan, Jonathan M. Spergel, Edaire Cheng, Evan S. Dellon, Ikuo Hirano
Publikováno v:
The Journal of allergy and clinical immunology, vol 142, iss 1
The Consortium of Eosinophilic Gastrointestinal Diseases and the International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the recent 2018 Annual Meeting of the American Academy of Allergy, Asthma & Immunology, which was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1514cbb7fd21ca6a8c6ecfd14fd1eba
https://europepmc.org/articles/PMC6129859/
https://europepmc.org/articles/PMC6129859/
Autor:
Bridget Godwin, Chris Liacouras, Vijay Mehta, Joshua Eisenberg, Atu Agawu, Terri Brown-Whitehorn, Melanie A. Ruffner, Ritu Verma, Antonella Cianferoni, Jonathan M. Spergel, Amanda B. Muir
Publikováno v:
Frontiers in Pediatrics
Frontiers in Pediatrics, Vol 6 (2018)
Frontiers in Pediatrics, Vol 6 (2018)
Background: Eosinophilic esophagitis is a chronic, immune-mediated disease characterized by symptoms of esophageal dysfunction and ≥15 eosinophils/high-powered field (eos/hpf). Proton pump inhibitor responsive esophageal eosinophilia (1) is an enti
Eosinophilic esophagitis (EoE) is a chronic allergic (immune-mediated) disease that leads to esophageal dysfunction and feeding disorders in children. Foods, and possibly environmental triggers, cause an inflammatory response in the esophagus, leadin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763828bd65b27c04181e9b9681605019
https://europepmc.org/articles/PMC5000297/
https://europepmc.org/articles/PMC5000297/
Autor:
Glenn T. Furuta, Seema S. Aceves, Shaobo Guan, Lisa M. Fahey, Alain Benitez, Patrick M. A. Sleiman, Amanda B. Muir, Chris A. Liacouras, Jonathan M. Spergel, Prasanna M. Chandramouleeswaran, Hakon Hakonarson, Mei-Lun Wang, Antonella Cianferoni
Publikováno v:
Clinical and Translational Gastroenterology
Objectives TSLP has been shown to be associated with eosinophilic esophagitis (EoE). Specifically, children with EoE often have the nucleotides AA or AG instead of GG at the single nucleotide polymorphism position RS3806932. Presently, the phenotypic
Autor:
Melanie A Ruffner, Zhe Zhang, Kelly Maurer, Amanda B Muir, Antonella Cianferoni, Kathleen E Sullivan, Jonathan M Spergel
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 7, Pp n/a-n/a (2021)
Abstract Objective There are no disease‐modifying therapies for the treatment of eosinophilic oesophagitis (EoE), which is driven by non‐IgE‐mediated allergic inflammation. A recent clinical trial of milk epicutaneous immunotherapy (EPIT) has s
Externí odkaz:
https://doaj.org/article/5641dcfa155e4a82a471ee193b1615ad